Zegerid Study Shows Benefits For Immediate-Release PPI/Antacid

Santarus announces positive clinical trial results for its prescription Zegerid proton pump inhibitor/antacid as it pursues an OTC switch application for a lower-dose version of the combination product

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet